非酒精性脂肪性肝病与脂肪细胞型脂肪酸结合蛋白的相关性

周小莉; 何兰杰

doi:10.3969/j.issn.1001-5256.2013.12.010

非酒精性脂肪性肝病与脂肪细胞型脂肪酸结合蛋白的相关性

DOI: 10.3969/j.issn.1001-5256.2013.12.010

宁夏医科大学总医院心脑血管病医院内分泌科

详细信息

中图分类号: R575.5
计量
- 文章访问数: 218
- HTML全文浏览量: 21
- PDF下载量: 77
- 被引次数: 0
出版历程
- 收稿日期: 2013-09-16
- 出版日期: 2013-12-20

Relationship between nonalcoholic fatty liver disease and adipocyte fatty acid- binding protein

Cardio-Cerebrovascular Disease Hospital, General Hospital of Ningxia Medical University

摘要

摘要: 目的通过测定患者血清脂肪细胞型脂肪酸结合蛋白(AFABP)水平,探讨血清AFABP与非酒精性脂肪性肝病(NAFLD)的相关性。方法选取2010年7月至2010年11月于宁夏医科大学附属医院体检的人员160例。根据中华医学会非酒精性脂肪性肝病诊断标准将观察对象分为对照组(71例)和NAFLD组(89例),分别比较两组间一般情况、身体质量指数(BMI)、血压、AFABP、血清胰岛素及血清学指标等各项病例资料。Spearman相关用于进一步分析血清AFABP与NAFLD及各代谢指标的相关性。计量资料组间比较采用t检验和秩和检验,计数资料组间比较采用χ2检验。结果 NAFLD组患者以男性为多,且与对照组比较,其存在更高的BMI、血糖、甘油三酯(TG)、ALT、AST及尿酸水平亦较高,而HDL水平较低;NAFLD组患者血清AFABP、胰岛素及胰岛素抵抗指数水平均高于对照组,差异有统计学意义;将AFABP与各参数进行Spearman相关分析研究显示,血清AFABP与NAFLD、BMI、胰岛素抵抗指数、血清胰岛素、血糖、TG、ALT、AST及尿酸水平呈正相关,而与HDL水平呈负相关;校正性别、年龄及...
- 脂肪肝 /
- 脂肪酸结合蛋白质类
Abstract: Objective To investigate the relationship between nonalcoholic fatty liver disease ( NAFLD) and serum level of adipocyte fatty acid-binding protein ( AFABP) . Methods A total of 160 patients who underwent physical examination in the Affiliated Hospital of Ningxia Medical University from July to November 2010 were included in our study. These subjects were divided into two groups according to the diagnostic criteria for NAFLD formulated by the Chinese Medical Association: control group ( n = 71) and NAFLD group ( n = 89) . The two groups were compared with respect to general condition, body mass index ( BMI) , blood pressure, AFABP, serum insulin, and other serological indices. The relationship of serum AFABP with NAFLD and other metabolic parameters was analyzed using the Spearman linear correlation coefficient. Comparison of measurement data was made by t test and rank sum test; comparison of enumeration data was made by chi-square test. Results There were more males than females in the NAFLD group. Compared with the control group, the NAFLD group had higher BMI and levels of blood glucose, triglyceride ( TG) , aspartate aminotransferase ( AST) , alanine aminotransferase ( ALT) , and uric acid and lower high-density lipoprotein ( HDL) level; in addition, the NAFLD group had significantly higher serum AFABP and insulin levels and homeostasis model assessment-estimated insulin resistance ( HOMA-IR) . The Spearman correlation analysis showed that serum AFABP was positively correlated with NAFLD, BMI, HOMA-IR, serum insulin, blood glucose, TG, ALT, AST, and uric acid but negatively correlated with HDL. After adjustment for sex, age, and BMI, serum AFABP was positively correlated with NAFLD, HOMA-IR, serum insulin, blood glucose, TG, ALT, and uric acid, but had no significant correlation with HDL and AST. Conclusion Serum AFABP is closely associated with NAFLD and may be an independent plasma marker of this disease. AFABP plays a causative role in the pathogenesis of NAFLD.
- fatty liver /
- fatty acid-binding proteins

HTML全文

参考文献(21)

[1]DAY CP.Non-alcoholic fatty liver disease:current concepts and management strategies[J].Clin Med, 2006, 6:19-25.

[2]CHALASANI N, YOUNOSSI Z, LAVINE JE, et al.The diagnosis and management of non-alcoholic fatty liver disease:practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenteroloy, and the American Gastroenterological Association[J].Hepatology, 2012, 55 (6) :2005-2023.

[3]MAEDA K, CAO H, KONO K, et al.Adipocyte/macrophage fatty acid binding proteins control integrated metabolic responses in obesity and diabetes[J].Cell Metab, 2005, 1 (2) :107-119.

[4] Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association, Chinese Medical Association.Guidelines for prevention and treatment of nonalcoholic liver disease (revised version 2010) [J].J Clin Hepatol, 2010, 26 (2) :120-124. (in Chinese) 中华医学会肝病学分会脂肪肝和酒精性肝病学组.非酒精性肝病诊疗指南 (2010年修订版) [J].临床肝胆病杂志, 2010, 26 (2) :120-124.

[5]WEI C, YANG WM, YE ZQ.The expression and significance of FABP protein in bladder carcinoma tissue[J].J Clin Urol, 2008, 23 (1) :65-66. (in Chinese) 卫超, 杨为民, 叶章群.膀胱移行细胞癌脂肪细胞型脂肪酸结合蛋白的表达及其意义[J].临床泌尿外科杂志, 2008, 23 (1) :65-66.

[6]XU A, TSO AW, CHEUNG BM, et al.Circulating adipocyte fatty acid binding protein levels predict the development of the metabolic syndrome:a 5-year prospective study[J].Circulation, 2007, 115 (12) :1537-1543.

[7]KOH JH, SHIN YG, NAM SM, et al.Serum adipocyte fatty acid–binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients[J].Diabetes Care, 2009, 32 (1) :147-152.

[8]KIM YC, CHO YK, LEE WY, et al.Serum adipocyte-specific fatty acid-binding protein is associated with nonalcoholic fatty liver disease in apparently healthy subjects[J].J Nutr Biochem, 2011, 22 (3) :289-292.

[9]XU A, WANG Y, XU JY, et al.Adipocyte fatty acid binding protein is a plasma biomarker closely associated with obesity and metabolic syndrome[J].Clin Chem, 2006, 52 (3) :405-413.

[10]KOH JH, LEE MY, SHIN YG, et al.Serum adipocyte fatty acid–binding protein levels are associated with nonalcoholic fatty liver disease in type 2 diabetic patients[J].Diabetes Care, 2009, 32 (1) :147-152.

[11]LI XJ.The study prospect of insulin resistance and insulin resistance syndrome[J].Chin J Endocrinol Metab, 2000, 16 (5) :274-276. (in Chinese) 李秀钧.胰岛素抵抗及胰岛素抵抗综合征研究展望[J].中华内分泌代谢杂志, 2000, 16 (5) :274-276.

[12]WANG Z, XIA B, MA C, et al.Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China[J].Postgrad Med J, 2007, 83 (977) :192-195.

[13]PARK JW, J EONG G, KIM SJ, et al.Predictors reflecting the pathological severity of nonalcoholic fatty liver disease:comprehensive study of clinical and immunohistochemical findings in younger Asian patients[J].J Gastroenterol Hepatol, 2007, 22 (4) :491-497.

[14]WU Z, XIE Y, MORRISON RF, et al.PPAR gamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBP alpha during the conversion of 3T3 fibroblasts into adipocytes[J].J Clin Invest, 1998, 101 (1) :22-32.

[15]RIBON V, JOHNSON JH, CAMP HS, et al.Thiazolidinediones and insulin resistance:peroxisome proliferator activated receptor gamma activation stimulates expression of the CAP gene[J].Proc Natl Acad Sci U S A, 1998, 95 (25) :14751-14756.

[16]MAKOWSKI L, BRITTINGHAM KC, REYNOLDS JM, et al.The fatty acid-binding protein, aP2, coordinates macrophage cholesterol traficking and infammatory activity.Macrophage expression of aP2impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities[J].J Biol Chem, 2005, 280 (13) :12888-12895.

[17]FURUHASHI M, TUNCMAN G, GRGN CZ, et al.Treatment of diabetes and atherosclerosis by inhibiting fatty acid binding protein, aP2[J].Nature, 2007, 447 (7147) :959-965.

[18]HUI X, LI H, ZHOU Z, et al.Adipocyte fatty acid-binding protein modulates inflammatory responses in macrophages through a positive feedback loop involving c-Jun NH2-terminal kinases and activator protein-1[J].J Biol Chem, 2010, 285 (14) :10273-10280.

[19]CAO H, MAEDA K, GORGUN CZ, et al.Regulation of metabolic responses by adipocyte/macrophage fatty acid–binding proteins in leptin-deficient mice[J].Diabetes, 2006, 55 (7) :1915-1922.

[20]TUNCMAN G, ERBAY E, HOM X, et al.A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease[J].Proc Natl Acad Sci U S A, 2006, 103 (18) :6970-6975.

[21]HUANG L, ZHOU DJ.The association of serum adipocyte fatty acid binding protein with adolescent obesity[D].Second Military Medical University, 2009. (in Chinese) 黄岚, 邹大进.血清脂肪细胞脂肪酸结合蛋白与青少年肥胖症的相关性研究[D].第二军医大学, 2009.

施引文献

资源附件(0)

访问统计